BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9780198)

  • 1. CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production.
    Marriott JB; Westby M; Cookson S; Guckian M; Goodbourn S; Muller G; Shire MG; Stirling D; Dalgleish AG
    J Immunol; 1998 Oct; 161(8):4236-43. PubMed ID: 9780198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.
    Fernández-Martínez E; Morales-Ríos MS; Pérez-Alvarez V; Muriel P
    Biochem Pharmacol; 2004 Oct; 68(7):1321-9. PubMed ID: 15345321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
    Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors.
    Punzón C; Alcaide A; Fresno M
    Int Immunopharmacol; 2003 Sep; 3(9):1293-9. PubMed ID: 12890427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meprin-alpha metalloproteases enhance lipopolysaccharide-stimulated production of tumour necrosis factor-alpha and interleukin-1beta in peripheral blood mononuclear cells via activation of NF-kappaB.
    Gao P; Si LY
    Regul Pept; 2010 Feb; 160(1-3):99-105. PubMed ID: 20026360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.
    Payvandi F; Wu L; Haley M; Schafer PH; Zhang LH; Chen RS; Muller GW; Stirling DI
    Cell Immunol; 2004 Aug; 230(2):81-8. PubMed ID: 15598423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.
    Shannon EJ; Sandoval F
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):59-72. PubMed ID: 8683039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B; Leng A; Mura A; Hengerer B; Feldon J
    J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of thalidomide on endotoxin-induced liver injury.
    Enomoto N; Takei Y; Hirose M; Kitamura T; Ikejima K; Sato N
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):2S-6S. PubMed ID: 12960498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide.
    van Crevel R; Vonk AG; Netea MG; Kullberg BJ; van der Meer JW
    Eur Cytokine Netw; 2000 Dec; 11(4):574-9. PubMed ID: 11125299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of gamma-plant preparation on production of TNF-alpha, IL-1 beta, and IL-6 in human peripheral blood mononuclear cells in vitro].
    Chekanovskaia LA; Generalov AV
    Vopr Med Khim; 2001; 47(2):263-73. PubMed ID: 11450448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues.
    Bradshaw M; Rutherford MS; Hoeper BJ; McWhinney CD; Borcherding DR; Schook LB; Edwards CK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1506-18. PubMed ID: 7791126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.
    Mazzoccoli L; Cadoso SH; Amarante GW; de Souza MV; Domingues R; Machado MA; de Almeida MV; Teixeira HC
    Biomed Pharmacother; 2012 Jul; 66(5):323-9. PubMed ID: 22770990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
    Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
    Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of recombinant bovine CD14.
    Wang Y; Zarlenga DS; Paape MJ; Dahl GE; Tomita GM
    Vet Res; 2003; 34(4):413-21. PubMed ID: 12911858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn.
    Pandey R; Maurya R; Singh G; Sathiamoorthy B; Naik S
    Int Immunopharmacol; 2005 Mar; 5(3):541-53. PubMed ID: 15683850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.